25-hydroxyvitamin D Levels and Coronary Heart Disease Risk Reclassification in Hypertension – Is it worth the “Hype”?

Similar Items

• The 25-hydroxyvitamin D(3) C-3 epimer: Distribution, correlates, and reclassification of 25-hydroxyvitamin D status in the population-based Atherosclerosis Risk in Communities Study (ARIC)
  od: Lutsey, Pamela L., i dr.
  Izdano: (2015)
• 25-hydroxyvitamin D levels, vitamin D binding protein gene polymorphisms and incident coronary heart disease among whites and blacks: the ARIC Study
  od: Michos, Erin D., i dr.
  Izdano: (2015)
• 25-Hydroxyvitamin D Levels Inversely Associate with Risk for Developing Coronary Artery Calcification
  od: de Boer, Ian H., i dr.
  Izdano: (2009)
• 25‐Hydroxyvitamin D Levels and Markers of Subclinical Myocardial Damage and Wall Stress: The Atherosclerosis Risk in Communities Study
  od: Michos, Erin D., i dr.
  Izdano: (2016)
• Factors Associated With Change in 25-Hydroxyvitamin D Levels Over Longitudinal Follow-Up in the ARIC Study
  od: McKibben, Rebeccah A., i dr.
  Izdano: (2016)